Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
HUTCHMED (China) Limited

HUTCHMED (China) Limited (HCM) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

HCM●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$14.15
$0.02(0.14%)
U.S. Market opens in 17h 7m

HUTCHMED (China) Limited (HCM)

Meyka AI Score

Z

Key Financials

Market Cap2.5B
P/E Ratio144.74
EPS (TTM)$2.67
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$13.40
3 Months$8.36
1 Year Target$14.58

HCM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of HUTCHMED (China) Limited (NASDAQ: HCM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, HUTCHMED (China) Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HCM on the NASDAQ shows an RSI of 59.56, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $14.58 for the NASDAQ listing.

Key metrics behind HUTCHMED (China) Limited's NASDAQ-traded stock include a P/E ratio of 144.74 and a market capitalization of 2.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HCM on the NASDAQ.

Price Performance (NASDAQ: HCM)

1-Day Change
0.14%
5-Day Change
1.29%
1-Month Change
14.30%
3-Month Change
32.12%
6-Month Change
2.46%
Year-to-Date (YTD) Change
6.15%
1-Year Change
-9.64%
3-Year Change
-16.47%
5-Year Change
-60.91%
All-Time (Max) Change
4.81%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

17,960 Employees
IPO DateMar 16, 2016
CountryHK
Actively Trading

Frequently Asked Questions